3M ESPE Ubistesin Forte
3M ESPE Ubistesin Forte 1/100 000 Articaine HCI 4% & Adrenaline 1:100,000 for complicated procedures requiring prolonged anaesthesia MMM15224 1.7ML CARTRIDGES (TIN OF 50) Contains 4% articaine and adrenaline 1/100,000 as a vasoconstrictor Contains only Sulphite as a stabiliser For adults and children aged 4 and over Average duration of action: - Pulp anaesthesia: approx. 75 minutes - Soft-tissue anaesthesia: > 240 minutes - Onset period of 1-3 minutes
3M ESPE Ubistesin Forte
3M ESPE Ubistesin dental anaesthetic.
Manufacturer
Stream the latest dental videos...
Sponsored Links...
Your account is currently locked
To unlock your account, you need to enter a Verification Code
that will be sent to your email address.
Click the button below to receive the Verification Code at
{email}
Sign in!
Contacting Support
Please complete the from below to contact technical support.
You will be contacted within 24 hours of lodging your support request.
Resetting Your Password
To reset your password, you need to enter a Verification Code that will be sent to your email address.
Click the button below to receive the Verification Code at
Resetting Your Password
Please enter your email address below and click CONTINUE.
Register Now!
Register now to join the Dental Community and access content restricted to the dental profession.
Please enter a password below.
- Password Conditions
- One Upper Case Letter
- One Lower Case Letter
- One Special Character
- One Number
- Length 8 Characters
Create Account
Dentevents.com is the continuing education calendar for dentistry. Your login lets you register for events from a growing list of associations, conference managers and industry bodies.
Your Dentist connects dental clinicians with patients in Australia, New Zealand and other locations. Your login lets you keep your details and details of your practice up-to-date.
The Dental Community gives you access to a suite of tools to help you in your professional life, regardless of your role in the dental profession. Use your login and see for yourself!
Plus you receive online access to the latest editions of...
By clicking “Create account” you agree to our terms of use and privacy policy including receiving email updates from us and our partners. You may unsubscribe at any time.
Nearly done!
We've sent an email to
Please enter the number contained in the email below.
Didn't get the email? Try checking your spam or junk folder. If you're still having trouble, please contact us.
Tuesday, 28 April, 2026